Prevalence of Cardiovascular-Kidney-Metabolic Syndrome Stages in US Adults, 2011-2020
Rahul Aggarwal(Brigham and Women's Hospital), Muthiah Vaduganathan(Brigham and Women's Hospital), John W. Ostrominski(Brigham and Women's Hospital)
Cited by 407
Related Papers
The Global Health and Economic Burden of Hospitalizations for Heart Failure
|Journal of the American College of Cardiology|2014|2k
Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials
|The Lancet|2022|969
SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials
|The Lancet|2022|881
Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
|New England Journal of Medicine|2024|693